Drugs Safety AlertFDA Adds New Safety Warning to ALTUVIIIO Label FDA Adds New Safety Warning to ALTUVIIIO Label Read Post »
ResearchClosed-Loop Insulin Delivery Systems: The New Standard Closed-Loop Insulin Delivery Systems: The New Standard Read Post »
Clinical TrailsBausch Health’s RED-C Program Comes Up Short in Phase 3 Bausch Health’s RED-C Program Comes Up Short in Phase 3 Read Post »
Policy & AcquisitionsPfizer Taps Novavax Matrix-M in New Licensing Deal Pfizer Taps Novavax Matrix-M in New Licensing Deal Read Post »
Clinical TrailsAbbott Shares Five-Year Data Showing Neuromodulation Therapy Cuts Pain-Rela... Abbott Shares Five-Year Data Showing Neuromodulation Therapy Cuts Pain-Rela... Read Post »
Clinical TrailsSanofi’s Amlitelimab Strengthens Phase 3 Evidence in Atopic Dermatitis wi... Sanofi’s Amlitelimab Strengthens Phase 3 Evidence in Atopic Dermatitis wi... Read Post »
New Drug ApprovalSun Pharma Wins DCGI Approval for Noveltreat, Generic Semaglutide Injection... Sun Pharma Wins DCGI Approval for Noveltreat, Generic Semaglutide Injection... Read Post »
New Drug ApprovalGSK’s Trelegy Ellipta Approved by NMPA in China for Adult Asthma GSK’s Trelegy Ellipta Approved by NMPA in China for Adult Asthma Read Post »
Policy & AcquisitionsJanux Therapeutics Inks $850M Deal with Bristol Myers Squibb for Tumor-Acti... Janux Therapeutics Inks $850M Deal with Bristol Myers Squibb for Tumor-Acti... Read Post »
Clinical TrailsCorcept Reports Overall Survival Benefit with Relacorilant in Platinum-Resi... Corcept Reports Overall Survival Benefit with Relacorilant in Platinum-Resi... Read Post »
Clinical TrailsBayer and BlueRock’s OpCT-001 Receives FDA Orphan Drug Designation for Re... Bayer and BlueRock’s OpCT-001 Receives FDA Orphan Drug Designation for Re... Read Post »
Clinical TrailsImmunityBio Advances ANKTIVA Toward FDA Resubmission in Papillary NMIBC ImmunityBio Advances ANKTIVA Toward FDA Resubmission in Papillary NMIBC Read Post »
Clinical TrailsFDA Grants Fast Track Designation to BioNTech’s BNT113 for HPV16-Positive... FDA Grants Fast Track Designation to BioNTech’s BNT113 for HPV16-Positive... Read Post »
Policy & AcquisitionsBristol Myers Squibb and Microsoft Partner to Advance AI-Driven Early Lung ... Bristol Myers Squibb and Microsoft Partner to Advance AI-Driven Early Lung ... Read Post »
Policy & AcquisitionsShionogi Expands Stake in ViiV Healthcare, Simplifying Ownership Structure ... Shionogi Expands Stake in ViiV Healthcare, Simplifying Ownership Structure ... Read Post »
Clinical TrailsFDA Grants Breakthrough Therapy Designation to Lilly’s Sofetabart Mipitec... FDA Grants Breakthrough Therapy Designation to Lilly’s Sofetabart Mipitec... Read Post »
Policy & AcquisitionsNovo Nordisk and Aspect Biosystems Expand Partnership to Develop Curative C... Novo Nordisk and Aspect Biosystems Expand Partnership to Develop Curative C... Read Post »
Clinical TrailsModerna–Merck mRNA Cancer Vaccine Combo Shows Durable Five-Year Recurrenc... Moderna–Merck mRNA Cancer Vaccine Combo Shows Durable Five-Year Recurrenc... Read Post »
Policy & AcquisitionsGSK Expands Immunology Portfolio with RAPT Therapeutics Takeover GSK Expands Immunology Portfolio with RAPT Therapeutics Takeover Read Post »
Health TidingsUltrahuman Partners With Click Therapeutics to Transform Migraine Managemen... Ultrahuman Partners With Click Therapeutics to Transform Migraine Managemen... Read Post »
Drugs Safety AlertOrganon’s NEXPLANON Now Approved for Up to Five Years of Contraception wi... Organon’s NEXPLANON Now Approved for Up to Five Years of Contraception wi... Read Post »
New Drug ApprovalEMA Validates ENHERTU Plus Pertuzumab for First-Line HER2 Positive Metastat... EMA Validates ENHERTU Plus Pertuzumab for First-Line HER2 Positive Metastat... Read Post »
Clinical TrailsSimcere and Lynk Report Positive Phase III Data for Zemprocitinib in Modera... Simcere and Lynk Report Positive Phase III Data for Zemprocitinib in Modera... Read Post »
New Drug ApprovalNMPA Review Begins for Envafolimab NDA in Biliary Cancer NMPA Review Begins for Envafolimab NDA in Biliary Cancer Read Post »
Drugs Safety Alert Health TidingsFDA Issues Warning Letter to Telangana’s Palamur Biosciences Over GLP Ris... FDA Issues Warning Letter to Telangana’s Palamur Biosciences Over GLP Ris... Read Post »
Health TidingsJapan Honors Daiichi Sankyo with Prime Minister’s Award for EZHARMIA, the... Japan Honors Daiichi Sankyo with Prime Minister’s Award for EZHARMIA, the... Read Post »
Lifestyle Research WellnessSmall Steps, Longer Lives: Lancet Study Links Minutes of Movement to Lower ... Small Steps, Longer Lives: Lancet Study Links Minutes of Movement to Lower ... Read Post »
Food WellnessEat Well, Fast Well: Simple Nutrition Strategies for Ramadan Eat Well, Fast Well: Simple Nutrition Strategies for Ramadan Read Post »
New Drug ApprovalEU Approves Eylea 8 mg for Retinal Vein Occlusion After Durable Results in ... EU Approves Eylea 8 mg for Retinal Vein Occlusion After Durable Results in ... Read Post »
Clinical TrailsAxsome Therapeutics Doses First Patient in Phase 3 FORWARD Trial of AXS-14 ... Axsome Therapeutics Doses First Patient in Phase 3 FORWARD Trial of AXS-14 ... Read Post »
Clinical TrailsJohnson & Johnson Presents New Evidence That CAPLYTA With Antidepressan... Johnson & Johnson Presents New Evidence That CAPLYTA With Antidepressan... Read Post »
New Drug ApprovalAtossa Therapeutics Secures FDA Orphan Drug Designation for (Z)-Endoxifen i... Atossa Therapeutics Secures FDA Orphan Drug Designation for (Z)-Endoxifen i... Read Post »
New Drug ApprovalNovartis’ Ianalumab Secures FDA Breakthrough Therapy Designation for Sjö... Novartis’ Ianalumab Secures FDA Breakthrough Therapy Designation for Sjö... Read Post »
Clinical TrailsAbbVie and Genmab Report Phase 3 Results for Epcoritamab in Relapsed DLBCL AbbVie and Genmab Report Phase 3 Results for Epcoritamab in Relapsed DLBCL Read Post »
Food WellnessHow Much Fiber Is Enough? The Truth About Fibermaxxing How Much Fiber Is Enough? The Truth About Fibermaxxing Read Post »
Clinical TrailsTeva’s AJOVY Demonstrates Strong Efficacy in Reducing Pediatric Migraine ... Teva’s AJOVY Demonstrates Strong Efficacy in Reducing Pediatric Migraine ... Read Post »
New Drug ApprovalChina NMPA Approves Two Sanofi-Licensed Innovative Therapies: Myqorzo (Afic... China NMPA Approves Two Sanofi-Licensed Innovative Therapies: Myqorzo (Afic... Read Post »
ResearchINGREZZA Shows Nearly Double VMAT2 Target Occupancy Compared to AUSTEDO XR ... INGREZZA Shows Nearly Double VMAT2 Target Occupancy Compared to AUSTEDO XR ... Read Post »
Clinical TrailsTanabe Pharma Reports Positive Phase 3 INSPIRE Results for MT-7117 in EPP a... Tanabe Pharma Reports Positive Phase 3 INSPIRE Results for MT-7117 in EPP a... Read Post »
Clinical TrailsPhase 3 MajesTEC-9 Trial Shows TECVAYLI® Monotherapy Improves Survival in ... Phase 3 MajesTEC-9 Trial Shows TECVAYLI® Monotherapy Improves Survival in ... Read Post »
Policy & AcquisitionsFDA, EMA Issue New Guidance on AI Use in Drug Development FDA, EMA Issue New Guidance on AI Use in Drug Development Read Post »
New Drug ApprovalAbbisko Therapeutics Achieves Major Milestone as FDA Accepts NDA for Pimico... Abbisko Therapeutics Achieves Major Milestone as FDA Accepts NDA for Pimico... Read Post »
New Drug ApprovalSebela Submits NDA for Tegoprazan as Potential First-in-Class P-CAB for GER... Sebela Submits NDA for Tegoprazan as Potential First-in-Class P-CAB for GER... Read Post »
Drugs Safety AlertFDA Removes Suicidal Ideation Warning From GLP-1 Weight-Loss Drugs FDA Removes Suicidal Ideation Warning From GLP-1 Weight-Loss Drugs Read Post »
Policy & AcquisitionsNVIDIA and Eli Lilly Bet $1B on AI-Driven Drug Discovery NVIDIA and Eli Lilly Bet $1B on AI-Driven Drug Discovery Read Post »
Clinical TrailsBristol Myers Squibb Reports Positive Phase 3 SCOUT-HCM Results for Camzyos... Bristol Myers Squibb Reports Positive Phase 3 SCOUT-HCM Results for Camzyos... Read Post »
New Drug ApprovalBiogen’s High-Dose SPINRAZA Approved in EU Following DEVOTE Study Results Biogen’s High-Dose SPINRAZA Approved in EU Following DEVOTE Study Results Read Post »
New Drug ApprovalGSK Receives EU Approval for Ready-to-Use Prefilled Syringe Shingrix GSK Receives EU Approval for Ready-to-Use Prefilled Syringe Shingrix Read Post »
Health TidingsAquestive Therapeutics Reports FDA-Identified Deficiencies in Anaphylm NDA,... Aquestive Therapeutics Reports FDA-Identified Deficiencies in Anaphylm NDA,... Read Post »
New Drug ApprovalFDA Accepts Camurus NDA Resubmission for Oclaiz™ in Acromegaly Treatment FDA Accepts Camurus NDA Resubmission for Oclaiz™ in Acromegaly Treatment Read Post »
New Drug ApprovalFDA Approves Zycubo (Copper Histidinate) Injection as First-Ever Treatment ... FDA Approves Zycubo (Copper Histidinate) Injection as First-Ever Treatment ... Read Post »
